Wang, Bofei
Reville, Patrick K. http://orcid.org/0000-0001-8433-3360
Yassouf, Mhd Yousuf http://orcid.org/0000-0001-7196-9503
Jelloul, Fatima Z. http://orcid.org/0000-0002-3791-3204
Ly, Christopher http://orcid.org/0000-0002-8620-3735
Desai, Poonam N.
Wang, Zhe
Borges, Pamella
Veletic, Ivo
Dasdemir, Enes http://orcid.org/0009-0007-0285-6266
Burks, Jared K. http://orcid.org/0000-0002-6173-9074
Tang, Guilin http://orcid.org/0000-0002-9482-4806
Guo, Shengnan
Garza, Araceli Isabella
Nasnas, Cedric http://orcid.org/0009-0009-2229-9756
Vaughn, Nicole R.
Baran, Natalia http://orcid.org/0000-0003-0618-4798
Deng, Qing
Matthews, Jairo
Gunaratne, Preethi H.
Antunes, Dinler A.
Ekmekcioglu, Suhendan http://orcid.org/0000-0003-4079-6632
Sasaki, Koji http://orcid.org/0000-0002-9140-0610
Garcia, Miriam B.
Cuglievan, Branko
Hao, Dapeng http://orcid.org/0000-0002-9043-371X
Daver, Naval http://orcid.org/0000-0001-7103-373X
Green, Michael R. http://orcid.org/0000-0001-6309-9472
Konopleva, Marina http://orcid.org/0000-0002-9347-2212
Futreal, Andrew http://orcid.org/0000-0001-8663-2671
Post, Sean M.
Abbas, Hussein A. http://orcid.org/0000-0003-2946-3562
Article History
Received: 7 July 2023
Accepted: 5 February 2024
First Online: 28 February 2024
Competing interests
: M.R.G reports research funding from Sanofi, Kite/Gilead, Abbvie and Allogene; consulting for Abbvie, Allogene and Bristol Myers Squibb; honoraria from BMS, Daiichi Sankyo and DAVA Oncology; and stock ownership of KDAc Therapeutics. I.V. received research funding from Avilect Biosciences/Aviceda Therapeutics. H.A.A. reports research funding from Genentech and Enzyme-By-Design, consultancy fees from Molecular Partners, and inkind support from Illumina.